Abstract
Objective: To analyze the impact of specific therapies on the treatment of food allergies. Methods: : This study is an integrative literature review conducted using the PubMed, LILACS, and SciELO databases. The Health Sciences Descriptors (DeCS) applied were “Food Allergy,” “Treatment,” and “Immunotherapy.” Inclusion criteria comprised primary studies published in English, Portuguese, and Spanish within the last ten years, available in full text and free of charge on the selected platforms. Results: Oral and sublingual immunotherapy have demonstrated effectiveness in promoting desensitization in patients with food allergies, reaching tolerance rates of up to 67% to the allergen in some studies, especially when treatment is initiated early. Furthermore, the use of omalizumab, as well as low-dose protocols, contributes to improved safety profiles and better quality of life outcomes. Conclusion: Recent advances in immunological therapies have shown consistent effectiveness in managing food allergies, promoting desensitization, increasing the reaction threshold, and enhancing safety in cases of accidental exposure to allergens.
References
ABBAS AK, et al. Imunologia celular e molecular. 10 ed. Rio de Janeiro: Elsevier, 2023.
ALVARO M, MURARO A. Oral immunotherapy in food allergy: present and future. Anales de Pediatría, 2015; 82(4): 213-215.
BERZUINO MB, et al. Alergia alimentar e o cenário regulatório no Brasil. Revista Eletrônica de Farmácia, 2017; 14(2).
HUNTER H, et al. Oral Immunotherapy in Peanut-Allergic Adults Using Real-World Materials. Allergy, 2025; 80: 2310-2318
JONES SM, et al. Efficacy and Safety of Oral Immunotherapy in a Randomized, Placebo-Controlled Study of 1-3-Year Old Children with Peanut Allergy: Findings from the Immune Tolerance Network IMPACT Trial. Lancet, 2022; 399(10322): 359-371
KIM EH, et al. Desensitization and Remission after Peanut Sublingual Immunotherapy in 1- to 4-year-old Peanut-Allergic Children: a Randomized, Placebo-Controlled Trial. J Allergy Clin Immunol., 2024; 153(1): 173-181
MA D, ZHU R. Low-dose oral immunotherapy in immunoglobulin E-mediated food allergies. Frontiers in Immunology, 2024; 15: 1321863
MARTORELL-CALATAYUD C, et al. Oral Immunotherapy to Hake in 8 Pediatric Patients. J Investig Allergol Clin Immunol., 2019; 29(4): 294-296
MENDES KDS, et al. Revisão integrativa: método de pesquisa para a incorporação de evidências na saúde e na enfermagem. Texto & Contexto Enfermagem, 2008; 17(4): 758-764.
OLIVEIRA A, et al. Alergia alimentar: Prevalência através de estudos epidemiológicos. Revista de Ciências da Saúde Nova Esperança, 2018; 16(1): 7–15.
OLIVEIRA LCL, et al. Atualização em alergia alimentar 2025: posicionamento conjunto da Associação Brasileira de Alergia e Imunologia e Sociedade Brasileira de Pediatria. Arquivos de Asma, Alergia e Imunologia, 2025; 9(1): 5-96.
RANGEL-GARZA L, et al. La práctica clínica de la inmunoterapia con alérgenos en México según 277 alergólogos encuestados durante un curso trianual. Rev Alerg Mex., 2020; 67(1): 1-8
SCHWORER AS, KIM EH. Sublingual immunotherapy for food allergy and its future directions. Immunotherapy, 2020; 12: 949-961.
SINDHER SB, et al. The Role of Biologics in the Treatment of Food Allergy. Journal of Allergy and Clinical Immunology: In Practice, 2024; 12(3): 562-568.
SOLÉ D, et al. Consenso brasileiro sobre alergia alimentar: 2018 – Parte 2 – Diagnóstico, tratamento e prevenção. Arquivos de Asma, Alergia e Imunologia, 2018; 2(1): 39-82.
SOUZA MT, et al. Revisão integrativa: o que é e como fazer. Einstein, 2010; 8(1): 102-106.
TAKAHASHI M, et al. Oral immunotherapy combined with omalizumab for high-risk cow's milk allergy: a randomized controlled trial. Scientific Reports, 2017; 7: 17453
VICKERY BP, et al. AR101 Oral Immunotherapy for Peanut Allergy. N Engl J Med., 2018; 379(21): 1991-2001.
WHITTEMORE R, KNAFL K. The integrative review: updated methodology. Journal of Advanced Nursing, 2005; 52(5): 546-553.
WOOD RA, et al. A Randomized Double-Blind Placebo-Controlled Study of Omalizumab Combined with Oral Immunotherapy for the Treatment of Cow's Milk Allergy. J Allergy Clin Immunol., 2016; 137(4): 1103-1110.
WOOD RA, et al. Omalizumab for the Treatment of Multiple Food Allergies. N Engl J Med., 2024; 390(10): 889-899
YONAMINE GH, PINOTTI R. Alergia alimentar: alimentação, nutrição e terapia nutricional. Barueri: Manole, 2021; 31-34p.
ZAVARISE LF, et al. Abordagens pediátricas para o manejo de alergias alimentares. Brazilian Journal of Implantology and Health Sciences, 2025; 7(1): 1536-1550.
